BCI Marketplace
Spinal Cord Interface trials

Implantable Wireless Brain-Machine Interface System for Spinal Cord Injury: Efficacy and Safety Study

RecruitingNCT07603752Phase: NAStarted 2026-04-28

Summary

This is a prospective, open-label, multi-center, single-arm study to evaluate the efficacy and safety of an implantable wireless brain-machine interface (BMI) system in patients with spinal cord injury. Eligible participants will undergo screening after signing informed consent, followed by BMI system implantation. Follow-up visits will be conducted postoperatively to assess brain-control performance and safety.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Inclusion Criteria: 1. Aged 18 to 65 years old (inclusive), with no restriction on gender. 2. Meeting all the following requirements: (1) Suffering from complete or incomplete tetraplegia secondary to cervical spinal cord injury (C2-C6); (2) Diagnosed in line with the 2019 revised International St

Locations

Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →